返回排名列表

The Ensign Group, Inc. (ENSG)

NEUTRAL
HealthcareMedical Care FacilitiesUnited States

基本面

68

价格

$178.44

市值

$10.57B

第一部分 · 这家公司值多少

概览

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

资产负债表与流动性

营收

$5.46B

最近12个月(截至2026/6/30)

净利润

$379M

最近12个月(截至2026/6/30)

自由现金流

-

股东权益合计

$2.23B

负债合计

$3.23B

流动比率

1.21

利息覆盖率

59.99

债务/EBITDA

4.25

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

合理估值

公允价值

$154.78

当前价格

$178.44

安全边际

-15.3%

公允价值区间

$100.60 - $208.95

估算方法

Analyst Target:$220.00
DCF:$93.59
PE-based:$139.36
Graham Growth:$202.81
EPV:$75.66
分析师共识:强力买入 (10B / 2H / 0S)
最近财报超预期:+2.16%

估值指标

市盈率(P/E)

28.11

ROE

15.4%

市净率(P/B)

4.28

P/FCF

-

毛利率

20.3%

ROIC

7.6%

盈利能力雷达图

Value Creation (Economic Moat)

ROIC

7.6%

WACC

6.8%

ROIC − WACC

+0.8 pp

ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.

基本面分析标准

通过(17)

  • EPS shows upward trend
  • EPS CAGR 8.64%
  • Price CAGR 24.07%
  • ROIC 7.6%
  • Debt/Equity ratio
  • Operating Margin 8.6%
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 16.5%
  • Revenue Growth 5Y 16.1%
  • Analyst Consensus 83% Buy
  • Earnings Quality (OCF/NI) 1.61
  • Share Dilution 1.2%
  • Piotroski F-Score 5/9

未通过(7)

  • Gross Margin 20.3%
  • P/B Ratio 4.28
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.7%
  • PEG Ratio 2.02
  • Net Margin Trend 6.9% vs 7.0%

不可用(4)

  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity

Piotroski F-评分

5/9

信号混杂:部分领域需关注

score
criteria

盈利质量

1.61

高质量:盈利有现金流支撑

股权稀释

1.2%

股份数量稳定

公司治理

管理团队

姓名职位年龄
Mr. Barry R. PortCEO & Chairman of the Board51
Mr. Spencer W. BurtonPresident & COO46
Ms. Suzanne D. Snapper CPACFO, Executive VP & Director51
Mr. Chad A. Keetch J.D.Chief Investment Officer, Executive VP & Secretary47
Ms. Beverly B. WittekindExecutive VP & General Counsel60
Kevin ReesePresident of Keystone Healthcare Inc-

审计风险

7

董事会风险

5

薪酬风险

7

股东权利风险

2

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

Latest News

Recent headlines for ENSG, sourced from Markets Gazette.

No recent news for ENSG.